業績

2021年

原著

No. 論文題名 発表雑誌
著者 発行の巻(号)頁,年
1 Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant
Shiratori S, Sugita J, Ota S, Kasahara S, Ishikawa J, Tachibana T, Hayashi Y, Yoshimoto G, Eto T,
Iwasaki H, Harada M, Matsuo K, Teshima T; the Japan Study Group for Cell Therapy and
Transplantation (JSCT).
56(1):129-136, 2021
2 Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105). Br J Haematol
Maruyama D, Iida S, Ogawa G, Fukuhara N, Seo S, Miyazaki K, Yoshimitsu M, Kuroda J,
Tsukamoto N, Tsujimura H, Hangaishi A, Yamauchi T, Utsumi T, Mizuno I, Takamatsu Y,
Nagata Y, Minauchi K, Ohtsuka E, Hanamura I, Yoshida S, Yamasaki S, Suehiro Y, Kamiyama Y,
Tsukasaki K, Nagai H.
192(3):531-541, 2021
3 A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial. Blood Adv
Ohmachi K, Kinoshita T, Tobinai K, Ogawa G, Mizutani T, Yamauchi N, Fukuhara N, Uchida T,
Yamamoto K, Miyazaki K, Tsukamoto N, Iida S, Utsumi T, Yoshida I, Imaizumi Y, Tokunaga T,
Yoshida S, Masaki Y, Murayama T, Yakushijin Y, Suehiro Y, Nosaka K, Dobashi N, Kuroda J,
Takamatsu Y, Maruyama D, Ando K, Ishizawa K, Ogura M, Yoshino T, Hotta T, Tsukasaki K,
Nagai H; the Japan Clinical Oncology Group.
5(4):984-993, 2021
4 Bortezomib enhances G-CSF-induced hematopoietic stem cell mobilization by decreasing CXCL12 levels and increasing vascular permeability. Exp Hematol
Matsumoto T, Takamatsu Y, Moriyama H, Terada K, Mori M, Ono K, Migita K, Hara S. 97:21-31, 2021.5
5 Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008. Int J Hematol
Morishige S, Miyamoto T, Eto T, Uchida N, Kamimura T, Miyazaki Y, Ogawa R, Okumura H,
Fujisaki T, Iwasaki H, Kawano N, Wake A, Ohta T, Takamatsu Y, Kurokawa T, Ito Y, Maeda T,
Akashi K, Nagafuji K.
113(6):815-822, 2021.6
6 Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults. Diagn Pathol
Wang Z, Kimura S, Iwasaki H, Takase K, Oshiro Y, Gamachi A, Makihara K, Ogata M, Daa T,
Momosaki S, Takamatsu Y, Takeshita M.
16(1):48-57, 2021.6.4
7 Programmed cell death-ligand 1 (PD-L1)+ tumour cells and low-reacting programmed cell death 1 (PD1)+ tumour-infiltrating lymphocytes predict poor prognosis in Epstein-Barr virus+ diffuse large B-cell lymphoma. Clin Exp Med
Kimura S, Oshiro Y, Iwasaki H, Kadowaki M, Mihashi Y, Sakata T, Kawauchi S, Wang Z,
Takamatsu Y, Takeshita M.
doi:10.1007/s10238-021-00754-4. Online ahead of print.
2021.9.13
8 A questionnaire survey on evaluation for penetration and compliance of the Japanese Guideline on Febrile Neutropenia among hematology-oncology physicians and surgeons. Support Care Cancer
Akiyama N, Okamura T, Yoshida M, Kimura S, Yano S, Yoshida I, Kusaba H, Takahashi K, Fujita H,
Fukushima K, Iwasaki H, Tamura K, Saeki T, Takamatsu Y, Zenda S.
29(11):6831-6839, 2021.11
9 Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers. Diagn Pathol
Mihashi Y, Kimura S, Iwasaki H, Oshiro Y, Takamatsu Y, Kawauchi S, Shimajiri S, Ishizuka K,
Takeshita M.
16(1):101-110, 2021.11.6
10 Experience of rehabilitation for patients with mild and moderate COVID-19 without remote systems. Int J Phys Med Rehabil
Kamada S, Fujimi K, Shiota E, Harada T, Ishizu M, Hiyoshi T, Sakamoto A, Yamamoto T. 9(S8):1000003, 2021.12.21
11 Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons. Support Care Cancer
Akiyama N, Okamura T, Yoshida M, Kimura S, Yano S, Yoshida I, Kusaba H, Takahashi K, Fujita H,
Fukushima K, Iwasaki H, Tamura K, Saeki T, Takamatsu Y, Zenda S. 
doi:10.1007/ s00520-022-06834-9. Online ahead of print.
2022.1.29.
12 Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma. Sci Rep
Tanaka T, Sakai R, Choi I, Tsukada J, Sasaki H, Naito Y, Kiyomi F, Takamatsu Y, Tamura K. doi:10.1038/s41598-022-07164-w.
12(1):3124-3133,
2022.2.24
13 Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia–lymphoma patients receiving mogamulizumab. Br J Haematol
Nosaka K, Kusumoto S, Nakano N, Choi I, Yoshimitsu M, Imaizumi Y, Hidaka M, Sasaki H,
Makiyama J, Ohtsuka E, Jo T, Ogata M, Ito A, Yonekura K, Tatetsu H, Kato T, Kawakita T,
Suehiro Y, Ishitsuka K, Iida S, Matsutani T, Utsunomiya A, Ueda R, Ishida T.
196(3):629-638, 2022.2
14 Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study. Int J Hematol
Onishi C, Nishikori M, Yakushijin K, Kurahashi S, Nakazawa H, Takamatsu Y, Hashimoto Y,
Tatetsu H, Nawa Y, Yoshida M, Kobayashi T, Oyake T, Yano S, Oride A, Suzuki R.
115(3):382-390,
2022.3
15 Mapping the human genetic architecture of COVID-19 Nature
Takata T. (Collaborator) 600(7889):472-477, 2021.12.16
16 Oral health of COVID-19 patients using extracorporeal membrane oxygenation: A clinical study of 19 cases. J Clin Med
Yoshino A, Nakamura Y, Irie Y, Kitamura T, Takata T, Ishikura H, Kondo S. doi:10.3390/jcm11010042.
11(1):42, 2021.12.23
17 Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia. Diagn Microbiol Infect Dis
Yoshimura M*, Tokushige C, Maruyama JI, Kawano Y, Ishikura H, Matsunaga A, Takata T,
Hiromatsu K, Yanagihara I, Togawa A*, Takamatsu Y.(*Corresponding author)
doi:10.1016/j.diagmicrobio.2022. 115633. Online ahead of print.
102(4):115633,
2022.1.15

ページの先頭へ戻る

症例報告

No. 論文題名 発表雑誌
著者 発行の巻(号)頁,年
1 A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature. Medicine(Baltimore)
Tamaki K, Mera H, Takeshita S, Fujioka S, Goto M, Matsumoto T, Yamano Y, Takamatsu Y,
Tsuboi Y.
100(40):e27450,2021.10.8.
2 Epstein-Barr virus-positive intestinal diffuse large B-cell lymphoma in a Japanese patient with celiac disease: First reported case and a literature review. Intern Med
Ishibashi H, Imakiire S, Goto M, Nomaru R, Shibata M, Matsuoka H, Yasuda H, Yamashima T,
Sakisaka H, Tanabe T, Matsuoka S, Kuno N, Abe K, Funakoshi S, Takamatsu Y, Hirai F,
Takeshita M.
61(3):329-334,2022.2.1.
3 Focal segmental glomerulosclerosis and concurrent glomerular microangiopathy after long-term imatinib administration. CEN Case Rep
Morita N, Ozaki T, Yokota S, Sasaki H, Watanabe M, Takahashi K, Himuro N, Ito K, Yasuno T,
Miyake K, Nawata A, Nakayama T, Uesugi N, Masutani K.
11(1):134-140,2022.2

ページの先頭へ戻る

総説

No. 論文題名 発表雑誌 発行の巻(号)頁,年 著者
1 NK細胞の分化・成熟における転写因子ETS1の役割 血液内科 82(5):733-738, 2021.5 磯部 泰司
2 血球貪食性リンパ組織球症 血液内科 83(1):31-42, 2021.7 磯部 泰司
3 多発性骨髄腫やその他の形質細胞腫瘍に合併する神経症状 血液内科 83(6):778-785, 2021.12.28 知念 祥太郎、
髙松 泰
4 特集/かゆみ診療に必要な最新の知識 かゆみと疾患 造血器腫瘍 臨床と研究 99(3):46-50, 2022.3 茂木 愛、髙松 泰

ページの先頭へ戻る

著書

No. 著書名 発行所 頁, 年 著者
1 標準的医療説明 インフォームド・コンセントの最前線 第1版
(編集 一般社団法人 内科学系学会社会保険連合)
びまん性大細胞型B細胞リンパ腫に対する治療
医学書院 181-187, 2021.8.23 磯部 泰司
2 専門医のための血液病学(編集 鈴木隆浩、竹中克斗、池添隆之)
Ⅵ治療総論 1抗がん剤 1)抗がん剤総論
医学書院 320-325, 2022.3.15 髙松 泰
3 侵襲性カンジダ症に対するマネジメントのための臨床実践
ガイドライン(一般社団法人日本医真菌学会)
VII治療
1.侵襲性カンジダ症に対する治療 b.好中球減少患者
5.稀な侵襲性カンジダ症に対する治療 a.Clinical Question28:
慢性播種性カンジダ症(肝、脾)に対する治療は?
春恒社・
日本医真菌学会
36-46,105-109, 2021.8.31 髙田 徹
(侵襲性カンジダ症に対するマネジメントのための臨床実践ガイドライン作成員会)

ページの先頭へ戻る